Export 257 results:
[ Author
Filters: First Letter Of Last Name is C [Clear All Filters]
“Clinical trials Referral Resource. Clinical trials at the medicine branch of the NCI--Part I.”, Oncology (Williston Park), vol. 9, no. 4, pp. 292-4, 1995.
, “Clinical trials referral resource. Clinical trials at the surgery branch of the NCI.”, Oncology (Williston Park), vol. 9, no. 5, pp. 453-4, 1995.
, “Clinical trials referral resource. Clinical trials in adult acute myelogenous leukemia.”, Oncology (Williston Park), vol. 12, no. 2, p. 224, 227, 1998.
, “Clinical trials at the medicine branch of the NCI-part 2.”, Oncology (Williston Park), vol. 9, no. 6, pp. 506, 509-10, 1995.
, “Clinical Trials Referral Resource. Trials using tumor vaccines.”, Oncology (Williston Park), vol. 11, no. 1, pp. 81-2, 84, 90, 1997.
, “Summary results and recommendations from the age-related eye disease study.”, Arch Ophthalmol, vol. 127, no. 12, pp. 1678-9, 2009.
, “Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial.”, Am J Ophthalmol, vol. 159, no. 4, pp. 659-666.e1, 2015.
, “Experimental design issue for assessment of carotenoids lutein and zeaxanthin in age-related eye disease study 2 formulation for age-related macular degeneration--reply.”, JAMA Ophthalmol, vol. 132, no. 7, pp. 904-5, 2014.
, “Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2: Results From a Phase 1 Safety Trial”, Am J Ophthalmol, vol. 159, pp. 659-666.e1., 2015.
, “Evaluation of the age-related eye disease study clinical lens grading system AREDS report No. 31.”, Ophthalmology, vol. 117, no. 11, pp. 2112-9.e3, 2010.
, “Long-Term Effects of Vitamins C and E, β-Carotene, and Zinc on Age-Related Macular Degeneration: AREDS Report No. 35”, Opthalmology, vol. 120, pp. 1604-1611e.4, 2013.
, “The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study.”, Ophthalmology, vol. 110, no. 9, pp. 1683-9, 2003.
, “No Clinically Significant Association Between CFH and ARMS2 Genotypes and Response to Nutritional Supplements: AREDS Report Number 38”, Ophthalmology, vol. 121, pp. 2173-2180, 2014.
, “Ten-Year Follow-up of Age-Related Macular Degeneration in the Age-Related Eye Disease Study: AREDS Report No. 36”, JAMA Ophthalmol, vol. 132, pp. 272-277, 2014.
, “Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema.”, Retina, vol. 30, no. 3, pp. 459-67, 2010.
, “No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38.”, Ophthalmology, vol. 121, no. 11, pp. 2173-80, 2014.
, “Randomized Trial of the ForeseeHome Monitoring Device for Early Detection of Neovascular Age-Related Macular Degeneration. The HOme Monitoring of the Eye (HOME) Study Design - HOME Study Report Number 1”, Contemporary Clinical Trials, vol. 37, pp. 294-300, 2014.
, “Preliminary Assessment of Celecoxib and Microdiode Pulse Laser Treatment of Diabetic Macular Edema”, Retina, vol. 30, pp. 459-467, 2010.
“Serum Nutrient Levels as Risk Factors for Neovascular AMD”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2005.
, “Visual Acuity Loss Associated With Advanced AMD Fundus Lesions and With the Simplified AREDS AMD Severity Scale”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2007.
, “Experimental Design Issues for Assessment of Carotenoids Lutein and Zeaxanthin in Age-Related Eye Disease Study 2 Formulation for Age-Related Macular Degeneration”, JAMA Ophthalmol, vol. 132, pp. 904-905, 2014.
, , “Association of Cognitive Function and Depression with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2 (AREDS2)”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2009.
, “Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial.”, Ophthalmology, vol. 126, no. 4, pp. 540-549, 2019.
, “Randomized trial of the ForeseeHome monitoring device for early detection of neovascular age-related macular degeneration. The HOme Monitoring of the Eye (HOME) study design - HOME Study report number 1.”, Contemp Clin Trials, vol. 37, no. 2, pp. 294-300, 2014.
,